Swisse is harnessing the power of a little-known plant called Andrographis paniculata to relieve symptoms of the common cold and provide immune support.
Australian supplement firm Bod Australia will see George Livery — Swisse's former strategy and corporate director — join its ranks as executive chairman in September this year to drive the firm’s growth strategy in supplements and medical cannabis...
Researchers in Australia are continuing to explore the benefits of probiotics in relation to peanut allergy, buoyed by the findings of a follow-up study four years after their first published RCT.
A new Kiwi personalised nutrition supplement firm has attracted criticism from certain segments of the industry, thanks to its assertion that it is "beset with outlandish claims".
Customer service, environmental consciousness and constant innovation are crucial to longevity in the health and nutrition industry, according to Blackmores managing director Dave Fenlon.
Australian regulatory body the Therapeutic Goods Administration (TGA) will focus on education and detailed penalties for supplement advertisers who breach the rules as it implements new regulations.
Hopes have been raised that New Zealand's long-awaited new supplements bill could be revived after the country's trade association took part in an 'unexpectedly positive dialogue' with the government.
Insatiable demand from China is seeing infant formula fly off the shelves in Australia, resulting in shortages at retail stores and pharmacies, despite manufacturer efforts to increase production.
Australian pharmacists need specialised and targeted education on complementary medicines based on strong clinical evidence, according to a study led by the University of Canberra.
Bega Bionutrients, the health and ingredient arm of Australian firm Bega Cheese, has launched a novel form of microencapsulated infant formula ingredient lactoferrin – Inferrin.
